Medical Management of Intracranial Atheroclerotic Stenosis
نویسنده
چکیده
Intracranial atherosclerotic stenosis (ICAS) is a risk factor for ischemic stroke, and the primary aim of management is stroke prevention. The natural history of ICAS is influenced by symptomatic versus asymptomatic status, with symptomatic ICAS having a high recurrent stroke risk. The risk of stroke in symptomatic ICAS is dependent on many factors which will be reviewed in this chapter, including timing after symptoms, degree of stenosis, gender, and possibly other radiographic features (location of stenosis, radiographic progression). Medical management of symptomatic ICAS should include secondary prevention strategies. Based upon the WASID study, aspirin is preferred over Warfarin. Vascular risk factor modification should be promoted in all patients with ICAS to reduce recurrent stroke and vascular events. Despite medical therapy, symptomatic ICAS is associated with a significant recurrent stroke risk.
منابع مشابه
Is there a future for endovascular treatment of intracranial atherosclerotic disease after Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and Intracranial Stenosis (SAMMPRIS)?
The Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and Intracranial Stenosis (SAMMPRIS) trial, a randomized clinical trial comparing aggressive medical management to stenting with aggressive medical management for symptomatic intracranial stenosis, was prematurely halted when a high rate of periprocedural events was found in the stent arm. The trial also demonstrated...
متن کاملCost-effectiveness analysis of intracranial stent placement versus contemporary medical management in patients with symptomatic intracranial artery stenosis.
BACKGROUND Intracranial angioplasty and stent placement has been increasingly evaluated as a new method for treatment of symptomatic intracranial stenosis in select patients. The Food and Drug Administration (FDA) has approved intracranial stent treatment of symptomatic atherosclerotic intracranial lesions. PURPOSE To determine the cost-effectiveness of intracranial artery stent placement com...
متن کاملStenting versus aggressive medical therapy for intracranial arterial stenosis: more harm than good
BACKGROUND Atherosclerotic intracranial arterial stenosis is an important cause of stroke that is increasingly being treated with percutaneous transluminal angioplasty and stenting (PTAS) to prevent recurrent stroke. However, PTAS has not been compared with medical management in a randomized trial. METHODS Objective: To determine whether intracranial stenting (using the Wingspan self-expandin...
متن کاملEmerging Therapy Critiques
Symptomatic intracranial stenoses are an important cause of stroke and have a high risk of recurrent stroke with medical therapy. The Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Arterial Stenosis (SAMMPRIS) trial unexpectedly showed a higher-than-expected rate of complications with intracranial stenting and a lower-than-expected recurrence rate wit...
متن کاملAngioplasty and stenting for intracranial atherosclerotic stenosis: position statement of the Hong Kong Society of Interventional and Therapeutic Neuroradiology.
As a means of preventing secondary ischaemic stroke, angioplasty and stenting are considered potentially beneficial for patients with severe intracranial atherosclerotic stenosis. However, the role of stenting has been challenged since the publication of the first randomised controlled trial on Stenting versus Aggressive Medical Management for Preventing Recurrent stroke in Intracranial arteria...
متن کامل